Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Organon & Co.OGN · Entity 4115 | SVP and Corporate Controller | May 06, 2026 | May 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Organon & Co.
Report date May 06, 2026 · Filed May 07, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,448.366 |
Reported balance
After 2026-05-06 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-06 · Other · Acquired 45.939 · Balance 26,448.366 F1: This reflects the acquisition of 45.939 shares of common stock not previously required to be reported. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-05-06 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-05-06 · Sale · Disposed 26,448.366 · Balance 0 F2: This amendment updates the reporting of the 26,448.366 shares in Table I to reflect a sale (disposition) instead of a purchase. |
Filing footnotes · ownership attribution and instrument terms
F1: This reflects the acquisition of 45.939 shares of common stock not previously required to be reported.
F2: This amendment updates the reporting of the 26,448.366 shares in Table I to reflect a sale (disposition) instead of a purchase.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 06, 2026 Filed May 7, 2026 20:00 UTC Amendment | Organon & Co. OGN · Entity 4115 | SaleCommon Stock | 26,448.366 | $13.35 | $353,080.40 |
DisclosureSEC source: 0001628280-26-032059 · wk-form4a_1778184038.xml · nonDerivative · entry 2 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · balance_after: This amendment updates the reporting of the 26,448.366 shares in Table I to reflect a sale (disposition) instead of a purchase. Read SEC document |
| May 06, 2026 Filed May 7, 2026 20:00 UTC Amendment | Organon & Co. OGN · Entity 4115 | OtherCommon Stock | 45.939 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-032059 · wk-form4a_1778184038.xml · nonDerivative · entry 1 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,448.366 F1 · balance_after: This reflects the acquisition of 45.939 shares of common stock not previously required to be reported. Read SEC document |
| May 06, 2026 Filed May 7, 2026 14:02 UTC | Organon & Co. OGN · Entity 4115 | PurchaseCommon Stock | 26,448.366 | $13.35 | $353,080.40 |
DisclosureSEC source: 0001628280-26-031780 · wk-form4_1778162547.xml · nonDerivative · entry 1 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,850.793 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 6,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · derivative · entry 8 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Organon common stock. F6 · derivative.exercise_date: On March 31, 2025, the Reporting Person was granted 20,147 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. F6 · derivative.expiration_date: On March 31, 2025, the Reporting Person was granted 20,147 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 4,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · derivative · entry 7 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Organon common stock. F5 · derivative.exercise_date: On March 31, 2023, the Reporting Person was granted 12,755 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. F5 · derivative.expiration_date: On March 31, 2023, the Reporting Person was granted 12,755 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 41,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · derivative · entry 6 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,736 Underlying: Common Stock · 41,736 shares Expires not disclosed F3 · derivative.exercise_price: On March 31, 2026, the Reporting Person was granted 41,736 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. F3 · derivative.exercise_date: On March 31, 2026, the Reporting Person was granted 41,736 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. F3 · derivative.expiration_date: On March 31, 2026, the Reporting Person was granted 41,736 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | GrantRestricted Stock Units · Derivative | 75,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · derivative · entry 5 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,125 Underlying: Common Stock · 75,125 shares Expires not disclosed F2 · derivative.exercise_price: On March 31, 2026, the Reporting Person was granted 75,125 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. F2 · derivative.exercise_date: On March 31, 2026, the Reporting Person was granted 75,125 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. F2 · derivative.expiration_date: On March 31, 2026, the Reporting Person was granted 75,125 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,914 | $5.70 | $10,909.80 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · nonDerivative · entry 4 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,402.427 F1 · price: The price is the closing market price for Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 6,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · nonDerivative · entry 3 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,316.427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,212 | $5.70 | $6,908.40 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · nonDerivative · entry 2 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,601.427 F1 · price: The price is the closing market price for Organon & Co. ("Organon") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:06 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 4,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023139 · wk-form4_1775160371.xml · nonDerivative · entry 1 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,813.427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2026 Filed Mar 31, 2026 20:15 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 5,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-022421 · wk-form4_1774988138.xml · derivative · entry 3 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,319 Underlying: Common Stock · 5,319 shares Expires 2027-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU converts into one share of Organon common stock. F4 · derivative.exercise_date: These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027. F4 · derivative.expiration_date: These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027. Read SEC document |
| March 29, 2026 Filed Mar 31, 2026 20:15 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 1,516 | $5.84 | $8,853.44 |
DisclosureSEC source: 0001628280-26-022421 · wk-form4_1774988138.xml · nonDerivative · entry 2 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,561.427 F1 · price: This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units ("RSU") were awarded. F2 · balance_after: Includes the addition of 82 shares of Organon common stock acquired from dividend equivalents net of withholding tax not previously required to be reported. Read SEC document |
| March 29, 2026 Filed Mar 31, 2026 20:15 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 5,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-022421 · wk-form4_1774988138.xml · nonDerivative · entry 1 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,995.427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 21:04 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-051009 · wk-form4_1762808694.xml · derivative · entry 3 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,418 Underlying: Common Stock · 2,417 shares Expires 2026-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon & Co. common stock. F2 · derivative.exercise_date: 7,252 RSUs were granted 11/7/2023, and one-third vest each year with the final vesting date being 11/7/2026. Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 21:04 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 689 | $6.71 | $4,623.19 |
DisclosureSEC source: 0001628280-25-051009 · wk-form4_1762808694.xml · nonDerivative · entry 2 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,676.427 Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 21:04 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-051009 · wk-form4_1762808694.xml · nonDerivative · entry 1 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,365.427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 21:11 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionRestricted Stock Units · Derivative | 3,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-050186 · wk-form4_1762463515.xml · derivative · entry 3 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,076 Underlying: Common Stock · 3,037 shares Expires 2027-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Organon & Co. ("Organon") common stock. F2 · derivative.exercise_date: These restricted stock units vest and are distributed as shares of Organon common stock in three equal installments with the first vesting on November 5, 2025, and the final vesting date being on November 5, 2027. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 21:11 UTC | Organon & Co. OGN · Entity 4115 | Tax withholdingCommon Stock | 866 | $6.52 | $5,646.32 |
DisclosureSEC source: 0001628280-25-050186 · wk-form4_1762463515.xml · nonDerivative · entry 2 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,948.427 Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 21:11 UTC | Organon & Co. OGN · Entity 4115 | Exercise / conversionCommon Stock | 3,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-050186 · wk-form4_1762463515.xml · nonDerivative · entry 1 Holzbaur Lynette · CIK 0002068746 · SVP and Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,814.427 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.